Sandoz Company, a global player in generic pharmaceuticals has introduced in to Nigerian market Candesartan brand of products for management of cardiovascular disease particularly hypertension, left ventricular hypertrophy (LVH) and heart failure.
The introduction of the product by Sandoz, a Novarti
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Daniel Obi
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more
